BioArctic | BIOA Annual Report & Investor Relations Data
ISIN
SE0010323311
Ticker
BIOA
Sector
Sub-Industry
Country
Sweden
Year Founded
1992
ISIN
SE0010323311
Ticker
BIOA
Sector
Sub-Industry
Country
Sweden
Year Founded
1992
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as “disease modifiers”. They affect the underlying disease pathology and can hopefully stop or significantly delay disease progression. This is a large paradigm shift from today’s symptom-oriented therapies.
BioArctic’s proprietary technology platform, dedicated personnel, collaborations with leading academic research groups and the global pharma industry have made it possible to develop innovative treatments based on antibodies (immunotherapy) for neurodegenerative disorders.
Our main research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. Today there are no treatments that can stop or slow down the progression of these diseases.
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
700k+
filings covered
18
European countries
15min
max latency
1 API
for all filings
Limited spots available. Join now!
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 01.10.2024 | mikael smedeby | Other | Buy | SEK 105,902.70 |
| 29.07.2024 | Anna-Kaija Grönblad | Other | Buy | SEK 73,495.00 |
| 29.07.2024 | Anna-Kaija Grönblad | Other | Buy | SEK 73,100.00 |
| 18.02.2024 | Gunilla Margaretha Andersson | Other | Other | SEK 418,000.00 |
| 18.02.2024 | Gunilla Margaretha Andersson | Other | Sell | SEK 0.00 |
| 08.11.2023 | Eugen Steiner | Other | Buy | SEK 212,390.00 |
| 06.10.2023 | Johanna Margareta Fälting | Other | Sell | SEK 2,800,000.00 |
| 27.07.2023 | Cecilia Edström | Other | Buy | SEK 1,013,204.85 |
| 02.06.2023 | Sten Mikael Moge | Other | Sell | SEK 164,400.00 |
| 31.05.2023 | Oskar Bosson | Other | Sell | SEK 785,250.00 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …
ALACT
Sector
Health Care
Country
France
ISIN
FR0014005OJ5
Founded
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …
ACTI
Sector
Health Care
Country
Sweden
ISIN
SE0001137985
Founded
1998
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.